Nuveen Asset Management, LLC Y M Abs Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 112,483 shares of YMAB stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,483

Previous 112,483 -0.0%

Holding current value

$1.07 Million

Previous $1.36 Million 8.69%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$11.6 - $17.25 $1.8 Million - $2.68 Million	-155,247 Reduced 57.99%	112,483 $1.36 Million
Q1 2024 May 13, 2024	SELL	$6.57 - $18.69 $868,619 - $2.47 Million	-132,210 Reduced 33.06%	267,730 $4.35 Million
Q4 2023 Feb 14, 2024	BUY	$4.88 - $7.42 $202,720 - $308,234	41,541 Added 11.59%	399,940 $2.73 Million
Q3 2023 Nov 14, 2023	SELL	$4.86 - $7.23 $322,859 - $480,303	-66,432 Reduced 15.64%	358,399 $1.95 Million
Q2 2023 Aug 14, 2023	BUY	$5.68 - $10.34 $519,373 - $945,479	91,439 Added 27.43%	424,831 $2.88 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $5.11 $649,001 - $1.17 Million	229,329 Added 220.38%	333,392 $1.67 Million
Q4 2022 Feb 14, 2023	BUY	$3.0 - $15.17 $297 - $1,501	99 Added 0.1%	104,063 $508,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $56,705 - $79,899	-4,062 Reduced 3.76%	103,964 $1.5 Million
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $10,324 - $19,003	1,256 Added 1.18%	108,026 $1.63 Million
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $8,259 - $21,966	1,261 Added 1.2%	106,770 $1.26 Million
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $538,259 - $1.02 Million	-34,704 Reduced 24.75%	105,509 $1.62 Million
Q3 2021 Nov 12, 2021	SELL	$27.47 - $37.31 $588,187 - $798,881	-21,412 Reduced 13.25%	140,213 $4 Million
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $847,179 - $1.25 Million	33,288 Added 25.94%	161,625 $5.46 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $57,357 - $102,205	1,967 Added 1.56%	128,337 $3.88 Million
Q4 2020 May 17, 2021	SELL	$37.86 - $54.26 $477,944 - $684,978	-12,624 Reduced 9.08%	126,370 $6.26 Million
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $746,788 - $1.07 Million	19,725 Added 16.54%	138,994 $6.88 Million
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $1.14 Million - $1.42 Million	-32,461 Reduced 21.39%	119,269 $4.58 Million
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $1.04 Million - $2.18 Million	43,950 Added 40.78%	151,730 $6.56 Million
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $32,679 - $81,301	2,271 Added 2.15%	107,780 $2.81 Million
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $506,057 - $717,960	21,254 Added 25.23%	105,509 $3.3 Million
Q3 2019 Nov 14, 2019	BUY	$21.57 - $31.37 $93,980 - $136,679	4,357 Added 5.45%	84,255 $2.2 Million
Q2 2019 Aug 15, 2019	BUY	$19.51 - $28.31 $1.56 Million - $2.26 Million	79,898 New	79,898 $1.83 Million

Others Institutions Holding YMAB

# of Institutions

107

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $417M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Y M Abs Therapeutics, Inc. Transaction History